General Biotechnology

Health care costs in the US touched a staggering $3.2 trillion in 2015, which makes it one of the nation’s largest industries, equaling 17.8% of gross domestic product. This translates…
The post Factors driving healthcare costs in the US appeared…

Developing nations offer welcoming and growing markets as Abbott focuses exclusively on reformulating and marketing off-patent medications Driven by patient loyalty, prescriber preference, pharmacist trust, and traditional marketing, branded generics&#…

Formularies come into effect at the hospital level and the individual insurer level When developed and managed with due care and consideration, drug formularies can be a good tool for…
The post Formulary Decisions: Exploring the Ethics of Drug Ap…

Although currently tiny and narrowly focused on a handful of disease areas and countries, the biosimilar industry is set to expand as patents expire on top biologics, payers push for…
The post Top 5 Challenges Faced By Biosimilars appeared first …

For the last century, drug development consisted of tiny-molecule treatments focused at mass audience. It worked for some patients while it didn’t for the rest. In some cases, we knew…
The post Top 6 issues facing the biotechnology industry appea…

By: Pankaj Mondal, DrugPatentWatch Staff Writer When it comes to measuring the success of a new drug, the amount of time required to complete the entire approval process become a…
The post Accelerating Drug Approvals in the US appeared first on D…

Pharmaceutical competition incorporates different tactics in different markets because countries have divergent approaches to regulating healthcare costs. Both price and product have roles in defining the competitive landscape in pharmaceuticals,&#8230…